Richard T. Penson

ORCID: 0000-0002-8091-8588 · 2 papers in corpus

article 2021

A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient (MMR-P) recurrent or persistent endometrial cancer (EC).

·doi:10.1200/jco.2021.39.15_suppl.tps5609

TPS5609 Background: Despite significant strides in understanding the molecular pathogenesis of EC, there remain few effective therapies for recurrent disease. Deeper insight into the roles of disordered tumor vasculature and HIF1α- and VEGF…

review 2013

Clear cell cancer of the ovary

Current opinion in oncology ·doi:10.1097/CCO.0b013e328363e0c7

PURPOSE OF REVIEW: Recent discoveries have demonstrated that ovarian cancer is actually composed of multiple separate diseases. Clear cell cancer is an important example. This review will describe the unique biology of clear cell carcinoma,…